FDA TRT

Over the past five years, the FDA has undertaken a sweeping reassessment of testosterone replacement therapy (TRT) — from formulation approvals that expanded delivery options, to a landmark class-wide labeling overhaul driven by the TRAVERSE trial, to the most significant potential indication...